| Fibrinogen and atherosclerotic cardiovascular diseases—review of the literature and clinical studies S Surma, M Banach International Journal of Molecular Sciences 23 (1), 193, 2021 | 81 | 2021 |
| Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022) M Banach, S Surma, Z Reiner, N Katsiki, PE Penson, Z Fras, A Sahebkar, ... Cardiovascular Diabetology 21 (1), 263, 2022 | 60 | 2022 |
| The association between daily step count and all-cause and cardiovascular mortality: a meta-analysis M Banach, J Lewek, S Surma, PE Penson, A Sahebkar, SS Martin, ... European journal of preventive cardiology 30 (18), 1975-1985, 2023 | 57 | 2023 |
| Coffee and arterial hypertension S Surma, S Oparil Current hypertension reports 23 (7), 38, 2021 | 54 | 2021 |
| Periodontitis, blood pressure, and the risk and control of arterial hypertension: epidemiological, clinical, and pathophysiological aspects—review of the literature and … S Surma, M Romańczyk, J Witalińska-Łabuzek, MR Czerniuk, K Łabuzek, ... Current Hypertension Reports 23 (5), 27, 2021 | 54 | 2021 |
| Relationship between mental health and emotional eating during the COVID-19 pandemic: A systematic review E Burnatowska, S Surma, M Olszanecka-Glinianowicz Nutrients 14 (19), 3989, 2022 | 48 | 2022 |
| COVID-19 and lipids. The role of lipid disorders and statin use in the prognosis of patients with SARS-CoV-2 infection S Surma, M Banach, J Lewek Lipids in health and disease 20 (1), 141, 2021 | 44 | 2021 |
| Unexpected relationships: Periodontal diseases: Atherosclerosis–plaque destabilization? From the teeth to a Coronary Event MR Czerniuk, S Surma, M Romańczyk, JM Nowak, A Wojtowicz, ... Biology 11 (2), 272, 2022 | 39 | 2022 |
| Acute kidney injury in patients with COVID-19: Epidemiology, pathogenesis and treatment M Adamczak, S Surma, A Więcek Advances in Clinical and Experimental Medicine 31 (3), 317-326, 2022 | 30 | 2022 |
| Coffee or tea: Anti-inflammatory properties in the context of atherosclerotic cardiovascular disease prevention S Surma, A Sahebkar, M Banach Pharmacological Research 187, 106596, 2023 | 27 | 2023 |
| Targeted treatment against lipoprotein (a): the coming breakthrough in lipid lowering therapy B Sosnowska, S Surma, M Banach Pharmaceuticals 15 (12), 1573, 2022 | 26 | 2022 |
| Vitamin D and arterial hypertension: facts and myths M Adamczak, S Surma, A Więcek Current Hypertension Reports 22, 1-8, 2020 | 25 | 2020 |
| Evinacumab, an ANGPTL3 inhibitor, in the treatment of dyslipidemia B Sosnowska, W Adach, S Surma, RS Rosenson, M Banach Journal of Clinical Medicine 12 (1), 168, 2022 | 24 | 2022 |
| The effect of a vegan diet on the cardiovascular system M Koutentakis, S Surma, S Rogula, KJ Filipiak, A Gąsecka Journal of cardiovascular development and disease 10 (3), 94, 2023 | 23 | 2023 |
| Tips for effective implementation of virtual reality exposure therapy in phobias—a systematic review M Krzystanek, S Surma, M Stokrocka, M Romańczyk, J Przybyło, ... Frontiers in psychiatry 12, 737351, 2021 | 23 | 2021 |
| What is or what is not a risk factor for arterial hypertension? Not Hamlet, but medical students answer that question T Sobierajski, S Surma, M Romańczyk, K Łabuzek, KJ Filipiak, S Oparil International Journal of Environmental Research and Public Health 19 (13), 8206, 2022 | 22 | 2022 |
| Metabolic acidosis in patients with CKD: epidemiology, pathogenesis, and treatment M Adamczak, S Surma Kidney Diseases 7 (6), 452-467, 2021 | 21 | 2021 |
| Świadomość wybranych czynników ryzyka chorób układu sercowo-naczyniowego w populacji młodych osób S Surma, A Szyndler, K Narkiewicz Choroby Serca i Naczyń 14 (4), 186-193, 2017 | 21 | 2017 |
| A look to the past–what has had the biggest impact on lipids in the last four decades? A personal perspective M Banach, S Surma Archives of Medical Science: AMS 19 (3), 559, 2023 | 20 | 2023 |
| Angiopoietin-like proteins inhibitors: New horizons in the treatment of atherogenic dyslipidemia and familial hypercholesterolemia S Surma, M Romańczyk, KJ Filipiak Cardiology Journal 30 (1), 131-142, 2023 | 18 | 2023 |
Maciej BanachSecretary, European Atherosclerosis Society & President, International Lipid Expert Panel; Poland在 umed.lodz.pl 的电子邮件经过验证
